First case of toxic shock treated with haemoadsorption by cytosorb® in the Netherlands

doi:N/A

eISSN: None / ISSN: None

Netharland Journal of Critical Care

2016, Volume 24, Issue 2 : 27-29

Article

First case of toxic shock treated with haemoadsorption by cytosorb® in the Netherlands

van der Linde G.W.

Grootendorst A.F.

Abstract

Septic shock is one of the greatest challenges in intensive care medicine. Despite the development of several new therapies, morbidity and mortality remain high. The so-called holy grail has yet to be found. High-volume continuous renal replacement therapy has been subject to research for some time, with limited success. One of the novel therapies on septic shock is haemoadsorption with a CytoSorb® adsorber. We present the case of an adolescent with Staphylococcus aureus toxic shock syndrome treated with the CytoSorb® adsorber, who made a remarkable recovery afterwards. To the best of our knowledge, this was the first application of the CytoSorb® adsorber in the Netherlands. The effects of haemoadsorption with CytoSorbR have been investigated mainly in animal experimental studies; to date, there is very limited data on the use in human septic shock. © 2016, Netherlands Society of Intensive Care. All rights reserved.

Keywords

CytoSorb<sup>®</sup>

Haemoadsorption

Septic shock

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Neth. J. Crit. Care open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Right ventricular failure: Is it relevant for the intensivist?

van Dijk D.

96-97

Neuropsychological Predictors of Violent Criminal Behavior

Raymond H. Ellis,

Shruti Banerjee,

Kazuo Takayama

1-6

Postoperative renal replacement therapy after hydroxyethyl starch infusion: A meta-analysis of randomised trials

Wilkes M.M.,

Navickis R.J.